awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28075305-4D4A4324-1A73-42DE-A381-A3C09E39B41D
Q28075305-4D4A4324-1A73-42DE-A381-A3C09E39B41D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075305-4D4A4324-1A73-42DE-A381-A3C09E39B41D
Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma
P2860
Q28075305-4D4A4324-1A73-42DE-A381-A3C09E39B41D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075305-4D4A4324-1A73-42DE-A381-A3C09E39B41D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53dbb7e0c063904e0eff269df609ba4e8038f92f
P2860
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular cancer.